What intravenous medications can be used to treat opioid-induced pruritus?

IV Medications for Opioid-Induced Pruritus

For opioid-induced pruritus, use IV nalbuphine (2.5-5 mg) as first-line treatment, as it provides superior efficacy without compromising analgesia or causing significant adverse effects. 1

Treatment Algorithm

First-Line: Nalbuphine

• Dose: 2.5-5 mg IV (25-50% of analgesic dose)
• Mechanism: Mixed opioid agonist-antagonist
• Evidence: Systematic review demonstrates superiority over placebo, diphenhydramine, naloxone, and propofol 1
• Key advantage: Does not attenuate analgesia at low doses and may actually reduce nausea/vomiting 1
• Caution: In opioid-tolerant patients, may reduce analgesic effect or precipitate withdrawal 2

Second-Line: Low-Dose Naloxone

• Dose: 0.25 µg/kg/h continuous infusion 2
• Alternative dosing: 0.25-2.4 µg/kg/h has proven efficacy (NNT 3.5) 3
• Advantage: Can relieve pruritus without reversing analgesia when carefully titrated 4
• Critical point: Dose titration is essential—too high will reverse pain control

Third-Line: Nalmefene

• Dose: 0.5 µg/kg IV 5
• Evidence: 85% complete relief rate within 24 hours vs 64% placebo, with median relief time of 1.5 hours 5
• Advantage: Does not affect postoperative analgesia or increase adverse events 5
• Note: Conflicting data exists—one older study found 0.5-1 mg doses ineffective 3, but recent 2025 trial used weight-based dosing with success 5

Alternative Options

Ondansetron (5-HT3 antagonist)

• Guidelines note "conflicting data" 2
• Case reports show rapid relief within minutes 6
• Lack of robust RCT evidence for prevention 3
• Consider when opioid antagonists are contraindicated

Droperidol

• Dose: 2.5 mg IV
• Evidence: NNT 4.9 for prevention 3
• Important: Only IV route effective; epidural route ineffective 3
• Limitation: Primarily studied for prevention, not treatment of established pruritus

Context-Specific Considerations

Neuraxial Opioids

• Pruritus incidence is significantly higher with neuraxial vs IV opioids (up to 50-73% with intrathecal morphine) 7, 5
• Consider IV lidocaine infusion for cesarean delivery patients: 1.5 mg/kg bolus followed by 1.5 mg/kg/h for 6 hours reduces incidence from 73% to 36% (NNT 3) 7

Opioid Rotation Strategy

• If pruritus persists despite treatment, rotate from opiates (morphine, codeine) to synthetic opioids (fentanyl) 2, 4
• More common with morphine due to histamine release

What Doesn't Work

Ineffective interventions (avoid wasting time):

• Prophylactic propofol 3
• Epidural/intrathecal epinephrine 3
• Epidural clonidine 3
• Intramuscular hydroxyzine 3
• Nalmefene 0.5-1 mg (non-weight-based dosing) 3

Antihistamines (diphenhydramine, hydroxyzine):

• Guidelines suggest trying 2, 4, but systematic review shows lack of efficacy 3
• May provide sedation that masks symptoms rather than true relief
• Consider only after opioid antagonists fail

Critical Pitfalls

1. Don't use full antagonist doses: This reverses analgesia. Use 25-50% of typical analgesic doses for nalbuphine
2. Rule out other causes first: New medications, allergic reactions, skin conditions 4
3. Timing matters: Pruritus typically occurs early in treatment; if it develops with stable dosing, investigate other causes 2
4. Monitor opioid-tolerant patients closely: Mixed agonist-antagonists may precipitate withdrawal 2